Abstract
BackgroundSpatial architecture within the tumor microenvironment (TME) can potentially impact disease pathology, progression and treatment response of DLBCL. Additionally, activation of host’s immune system greatly determines response to immunotherapy treatments....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
